GALA Health

Global Alliance for Lungs, Air and Health

[GALA Health @GALA_Health]

Cities are built decisions. Where industry sits, how people move, what grows between buildings — these choices determine lung health outcomes decades before any clinic opens. Urban planning is respiratory health policy. It's time ministries treated it that way.

[GALA Health @GALA_Health]

New French data: of 106,689 patients receiving immune checkpoint inhibitors in 2021–2022, fewer than 1% were treated via hospital-at-home. Care pathways varied widely. Researchers flag room for expansion, but call for more evidence on…
https://t.co/kNLwzokJq8

[GALA Health @GALA_Health]

Clean air is infrastructure. Cities that have moved the needle on respiratory outcomes didn't do it through awareness campaigns — they did it through fuel standards, zoning reform, and transit investment. The evidence is clear. Political will remains the variable.…

[COPD ATHLETE @russwinn66]

Wonderful experience over the last 4 days at @EuroRespSoc
conference 2026. Running healthcare professionals through a COPD simulation bike challenge was a meaningful way of experiencing the challenges of living with #COPD
#ERS2026

[GALA Health @GALA_Health]

Cooking smoke kills more quietly than tobacco. Biomass fuels drive chronic respiratory disease across low-income households at scale — yet clean cooking rarely appears in NCD prevention frameworks. Community-level solutions exist. The gap is political will, not…

[GALA Health @GALA_Health]

Accelerated lung function decline is consistently linked to increased cardiovascular risk, according to a new systematic review in Thorax. Across 15 studies, HRs for CVD ranged from 1.06–1.36. The link to CVD mortality remains…
https://t.co/yFkTtAxXcp

[GALA Health @GALA_Health]

262 million people live with asthma globally. It remains one of the most underfunded chronic conditions relative to its burden — particularly in low- and middle-income countries where diagnosis is often absent entirely. Neglect here is a policy choice. #LungHealth

[ERS publications @ERSpublications]

ERJ Open Research: In patients with asthma, dupilumab treatment resulted in a redistribution of pulmonary blood volume toward the smaller vessels. This shift in blood volume was associated with improved patient-reported and clinical asthma outcomes. https://t.co/5804Hyn2mt

[Dr Alexey Kulikov @KulikovUNIATF]

Europe has plans for cancer and heart disease – lung 🫁 health is still waiting.

Getting #respiratory care right could help patients, ease hospital pressure and cut emissions all at once – but Europe still lacks a plan to make it happen.

https://t.co/A2cTTt74ao

[GALA Health @GALA_Health]

The diseases that kill the most aren't always the ones that receive the most funding. Priority shapes investment. Investment shapes scale. Scale determines who survives. That sequence isn't inevitable — it's a policy choice. #GlobalHealth

[Every Breath Counts @EBCCoalition]

Professor David Halpin, global #COPD expert, is in #Barcelona at #ERSCongress2026!

#COPD is the world’s #3 killer—3.4M deaths each year & rapidly 📈 👉 https://t.co/AuxYIH3JsZ

@cphfutures @UniofExeter @GOLD_COPD @FIRS_LungsFirst @EuroRespSoc #ERSCongress

[GALA Health @GALA_Health]

In recurrence-free LA-NSCLC survivors after trimodality therapy, treatment-related complications still shape long-term outcomes. A retrospective study found chronic lung injury beyond the anatomical segment was an independent prognostic…
https://t.co/kbIy9xfJwg

[GALA Health @GALA_Health]

Country health systems don't fail for lack of external prescriptions. They fail when local evidence goes unused and domestic capacity goes unbuilt. GALA works alongside governments — not above them. #GlobalHealth

[GALA Health @GALA_Health]

Helping countries integrate chronic respiratory disease into national health systems means more than writing guidelines. It means working inside ministries, aligning with financing structures, and making sure CRDs appear in UHC benefit packages — not as an…

[GALA Health @GALA_Health]

We advocate to transform chronic respiratory diseases #CRDs from a neglected condition into a clear priority within global and national #health and development agendas.

https://t.co/O6WwjHoFSQ

[COPD Foundation @COPDFoundation]

An estimated 375 million people around the world could benefit from safe, high-quality, and affordable medical oxygen to survive and thrive.

Unfortunately, many go without access.

Help us raise awareness about oxygen therapy leading up to #WorldOxygenDay on October “0-2!"

[European Lung Foundation @EuropeanLung]

📍 Today's ELF picks at #ERSCongress2026

🫁 Healthy Lungs for Life #BreatheCleanAir meeting (14:00–15:30)

🌍 #JARED EU project meeting (12:00–13:45)

🤝 Meet patient organisations @ApnoeaTrust, @AnesEspana & more

☕ ELF social hour (15:00–16:00)

#SOLACE #ELCSA @EuroRespSoc

[OncoDaily Lung @OncodailyLung]

Before #WCLC26, Walk Cheonggyecheon at Dusk - GILBERTO de lima LOPES Junior (@GlopesMd)

[Prof. Dr. Ahmet Dirican @dr_dirican]

What will define the next 25 years of cancer research?

A new Nature Reviews Cancer Viewpoint argues that oncology must move beyond describing established tumours towards predicting their future behaviour, intercepting disease before invasion and eliminating the capacity of residual cancer cells to restart tumour growth.

Two concepts particularly stand out. Minimal residual disease may not be defined adequately by the number of malignant cells that remain: a small population with high “restart potential” could be more clinically important than a larger population of irreversibly damaged cells.
Similarly, larger and more complex AI models are not automatically better biological models. Progress will depend on well-annotated datasets, rigorous benchmarks and cancer-specific computational tools.

This is a forward-looking expert Viewpoint rather than evidence supporting immediate clinical practice change.
Nevertheless, its central message is compelling: the future of oncology will depend not only on detecting and describing cancer, but on predicting how it will evolve, resist treatment and restart.

☑️https://t.co/WuHLYYvCad

#CancerResearch #PrecisionOncology #CancerGenomics #ArtificialIntelligence #TranslationalResearch
@oncodaily
@Nature
@NatureRevCancer
@dougflora2

[ERS @EuroRespSoc]

Great turnout for today’s sessions in the World Village Auditorium so far, with a full programme of sessions taking place today and tomorrow.

#ERSCongress